Skip to content

Tear Analysis by Isoelectric Focusing in Clinically Isolated Syndrome as Multiple Sclerosis Criterion

Tear Analysis by Isoelectric Focusing in Clinically Isolated Syndrome as Multiple Sclerosis Criterion Among Patients With or Without Lesions at the Magnetic Resonance Imaging (Oligoclonal Profile of Tears)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02043964
Acronym
POLAR
Enrollment
165
Registered
2014-01-23
Start date
2012-10-31
Completion date
2018-12-31
Last updated
2024-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Clinically Isolated Syndrome, Multiple Sclerosis

Keywords

Multiple Sclerosis, Clinically Isolated Syndrome, Tears, Isoelectric focusing, Oligoclonal profile

Brief summary

This is a multicentric and prospective study for the validation of a diagnostic method in multiple sclerosis. Our hypothesis is that there is a characteristic profile of tears that can be recognized in order to help in the diagnosis of this pathology and that could possibly replace the lumbar punction which is an invasive method. Semi-automatic and automatic techniques of isoelectric focusing will be developed for analyzing data from tears. These results will help in the identification of markers of this disease.

Interventions

PROCEDUREtears and cerebrospinal fluid sampling

All patients recruited in this study will undergo a cerebrospinal fluid sampling which is an invasive procedure included in the actual routine practice. In addition a sampling from eyes will be obtain using the Schirmer test to get tears from the lacrimal gland.

Sponsors

Lille Catholic University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 18 years old or more * Clinically isolated syndrome of less than 3 months of onset * Informed consent to participate

Exclusion criteria

* Progressive primary multiple sclerosis * Relapsing remitting multiple sclerosis * Persons wearing contact lenses * Ocular Infection * Corticoid treatment at least 30 days before sampling * Immunosuppressive or immunomodulatory treatment at least 3 months before sampling * Pregnancy or breast feeding * No coverage by the Social Insurance

Design outcomes

Primary

MeasureTime frameDescription
Test of the concordance coefficient between the analysis of tears and the analysis of cerebrospinal fluidtwo years afterTest of the concordance coefficient between the analysis of tears and the analysis of cerebrospinal fluid

Secondary

MeasureTime frameDescription
Diagnostic performance of isoelectric focusing of tearsinclusion, two years afterIdentification of the number of patients with a typical electrophoretic profile in tears allowing the early diagnosis of a SEP-RR
Concordance between visual and automatic reading of electrophoretic profilestwo yearsDetermination of percentage of positive and negative tests after visual and automatic reading of electrophoretic profiles
Calculation of sensitivity/specificitytwo yearsCalculation of sensitivity/specificity
Calculation of positive/negative predictive valuetwo yearsCalculation of positive/negative predictive value
Calculation of efficiency odds ratiotwo yearsCalculation of efficiency odds ratio

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026